Equillium (EQ) Cash from Operations (2018 - 2026)
Equillium (EQ) reported Cash from Operations of 4301000.0 for Q1 2026, up 47.35% year-over-year from 2918905.79 in Q1 2025, and down 37.28% quarter-over-quarter from 3133000.0 in Q4 2025.
Equillium (EQ) Cash from Operations (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Cash from Operations data on file, last reported at 4301000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 4301000.0, up 47.35% year-over-year; the trailing twelve-month figure through Mar 2026 was 18878000.0 (down 2.63% YoY), and the FY2025 annual result was 22746000.0, down 19.55% from the prior year.
- Cash from Operations slipped to 4301000.0 in Q1 2026 per EQ's latest filing, from 3133000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 27725000.0 in Q4 2022 and troughed at 13065000.0 in Q3 2022.
- A 5-year average of 4505235.29 and a median of 6215000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations jumped 373.61% in 2022, then tumbled 512.74% in 2025.
- A 5-year view of Cash from Operations shows it stood at 27725000.0 in 2022, then plunged by 120.43% to 5664000.0 in 2023, then jumped by 41.75% to 3299000.0 in 2024, then rose by 5.03% to 3133000.0 in 2025, then tumbled by 37.28% to 4301000.0 in 2026.
- Business Quant data shows EQ's Cash from Operations at 4301000.0 in Q1 2026, 3133000.0 in Q4 2025, and 8431000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | -4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.30 Mn |
| Mar 31, 2026 | -4.30 Mn |
| Dec 31, 2025 | -3.13 Mn |
| Dec 31, 2025 | -3.13 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Sep 30, 2024 | -7.66 Mn |
| Sep 30, 2024 | -7.66 Mn |
| Jun 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 730,000.00 |
| Mar 31, 2024 | -8.80 Mn |
| Mar 31, 2024 | -8.80 Mn |
| Dec 31, 2023 | -5.66 Mn |
| Dec 31, 2023 | -5.66 Mn |